SDIC
VRTX icon

South Dakota Investment Council’s Vertex Pharmaceuticals VRTX Stock Holding History

South Dakota Investment Council’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.86M Hold
6,400
– – 0.05% 250
2025
Q4 		$2.9M Sell
6,400
-480
-7% -$207K 0.06% 249
2025
Q3 		$2.69M Sell
6,880
-8,743
-56% -$3.65M 0.05% 265
2025
Q2 		$6.96M Sell
15,623
-10,780
-41% -$4.97M 0.13% 154
2025
Q1 		$12.8M Sell
26,403
-1,965
-7% -$916K 0.26% 79
2024
Q4 		$11.4M Hold
28,368
– – 0.23% 90
2024
Q3 		$13.2M Sell
28,368
-5,475
-16% -$2.63M 0.26% 84
2024
Q2 		$15.9M Sell
33,843
-969
-3% -$421K 0.33% 61
2024
Q1 		$14.6M Sell
34,812
-2,400
-6% -$1.01M 0.3% 71
2023
Q4 		$15.1M Sell
37,212
-1,400
-4% -$517K 0.32% 64
2023
Q3 		$13.4M Sell
38,612
-3,614
-9% -$1.26M 0.31% 65
2023
Q2 		$14.9M Sell
42,226
-6,675
-14% -$2.25M 0.31% 66
2023
Q1 		$15.4M Buy
48,901
+1,300
+3% +$390K 0.33% 62
2022
Q4 		$13.7M Sell
47,601
-11,813
-20% -$3.6M 0.31% 66
2022
Q3 		$17.2M Sell
59,414
-18,075
-23% -$5.2M 0.42% 41
2022
Q2 		$21.8M Sell
77,489
-16,006
-17% -$4.28M 0.5% 35
2022
Q1 		$24.4M Sell
93,495
-30,799
-25% -$7.31M 0.48% 33
2021
Q4 		$27.3M Buy
124,294
+45,680
+58% +$8.88M 0.46% 42
2021
Q3 		$14.3M Buy
78,614
+13,200
+20% +$2.58M 0.26% 88
2021
Q2 		$13.2M Buy
65,414
+23,820
+57% +$4.98M 0.23% 96
2021
Q1 		$8.94M Buy
41,594
+36,694
+749% +$8.06M 0.15% 138
2020
Q4 		$1.16M Buy
+4,900
New +$1.12M 0.02% 426

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

South Dakota Investment Council's VRTX Position: Q1 2026 in Review

South Dakota Investment Council held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 6,400 shares worth $2.86M. The position accounts for 0.05% of the portfolio, ranked #250.

South Dakota Investment Council first reported a position in VRTX in Q4 2020 and has held it in 22 quarters since. The position peaked at $27.3M in Q4 2021. 1,691 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • South Dakota Investment Council held 6,400 shares of Vertex Pharmaceuticals worth $2.86M as of Q1 2026.
  • South Dakota Investment Council left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.05% of South Dakota Investment Council's portfolio in Q1 2026, its #250 holding.
  • South Dakota Investment Council first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • South Dakota Investment Council's Vertex Pharmaceuticals position peaked at $27.3M in Q4 2021.
  • 1,691 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on South Dakota Investment Council's 13F filing for Q1 2026, filed 18 May 2026.